— Know what they know.
Not Investment Advice
Also trades as: 0K1R.L (LSE) · $vol 0M

VRDN NASDAQ

Viridian Therapeutics, Inc.
1W: +12.2% 1M: +14.0% 3M: +19.6% YTD: -23.9% 1Y: +5.8% 3Y: +98.5% 5Y: +40.4%
$24.09
+0.75 (+3.21%)
After Hours: $22.26 (-1.83, -7.62%)
Weekly Expected Move ±9.1%
$18 $20 $22 $24 $26
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 68 · $2.6B mcap · 106M float · 1.85% daily turnover · Short 57% of daily vol
Credit Risk of going bust: higher than 62% of companies Debt: 8.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.32 (down 99%), Viridian Therapeutics, Inc. would be worth roughly what it owes.
Total debt $242.9M against a stock market value of $2.64B.
Distance to default 4.10 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $121.8M (short-term plus half of long-term), stock volatility 74.2%; Altman Z'' 0.76. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
48.4 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 418.2%
Cost Advantage
34
Intangibles
49
Switching Cost
52
Network Effect
82
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. VRDN shows a Weak competitive edge (48.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 418.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$36
Low
$38
Avg Target
$39
High
Based on 3 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 14Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$37.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-22 RBC Capital — $36 $38 +2 +76.1% $21.58
2026-08-07 Truist Financial — $38 $39 +1 +70.0% $22.93
2026-08-07 RBC Capital Lisa Walter $34 $36 +2 +58.2% $22.76
2026-06-30 Truist Financial — $35 $38 +3 +102.2% $18.79
2026-06-30 Goldman Sachs — $40 $39 -1 +107.6% $18.79
2026-06-29 Wedbush Laura Chico $31 $43 +12 +130.4% $18.66
2026-06-29 Truist Financial Greg Renza $33 $35 +2 +89.8% $18.45
2026-06-29 Wells Fargo Derek Archila Initiated $31 — +66.8% $18.58
2026-05-15 Evercore ISI — $45 $26 -19 +54.2% $16.86
2026-05-13 Stifel Nicolaus — $48 $39 -9 +132.6% $16.77
2026-05-06 RBC Capital — $45 $34 -11 +81.3% $18.75
2026-04-21 Truist Financial — $36 $33 -3 +127.6% $14.50
2026-04-08 Truist Financial — $41 $36 -5 +148.8% $14.47
2026-04-08 Wedbush Laura Chico Initiated $31 — +114.2% $14.47
2026-02-26 Jefferies Kelly Shi Initiated $45 — +56.2% $28.80
2026-01-28 Evercore ISI Gavin Clark-Gartner $44 $45 +1 +35.8% $33.14
2026-01-20 Evercore ISI Gavin Clark-Gartner Initiated $44 — +34.8% $32.63
2026-01-07 UBS — Initiated $50 — +62.2% $30.82
2025-12-03 William Blair — Initiated $47 — +54.5% $30.43
2025-11-24 Truist Financial — Initiated $41 — +35.1% $30.34
2025-11-06 RBC Capital — $44 $45 +1 +63.6% $27.50
2025-11-06 Goldman Sachs — $25 $40 +15 +42.3% $28.11
2025-11-05 Stifel Nicolaus Alex Thompson $41 $48 +7 +98.0% $24.24
2025-10-21 Oppenheimer — $31 $36 +5 +47.0% $24.48
2025-10-21 H.C. Wainwright Douglas Tsao $27 $34 +7 +41.1% $24.09
2024-11-12 Stifel Nicolaus Alex Thompson $40 $41 +1 +259.3% $11.41
2024-09-13 RBC Capital Gregory Renza $35 $44 +9 +325.1% $10.35
2024-09-11 Needham Serge Belanger $45 $38 -7 +299.6% $9.51
2024-09-11 B.Riley Financial Kalpit Patel $20 $22 +2 +14.3% $19.24
2024-09-10 Stifel Nicolaus Alex Thompson Initiated $40 — +360.8% $8.68
2024-09-10 BTIG Julian Harrison $46 $56 +10 +548.1% $8.64
2024-08-14 Goldman Sachs Richard Law $23 $25 +2 +76.3% $14.18
2024-06-11 RBC Capital Gregory Renza Initiated $35 — +440.1% $6.48
2024-06-11 BTIG Julian Harrison Initiated $46 — +609.9% $6.48
2024-06-10 Wolfe Research Andy Chen Initiated $29 — +374.6% $6.11
2024-06-06 Goldman Sachs Richard Law Initiated $23 — +272.8% $6.17
2024-05-09 Oppenheimer Leland Gershell Initiated $31 — +316.1% $7.45
2024-05-09 H.C. Wainwright Douglas Tsao $35 $27 -8 +262.4% $7.45
2024-05-08 B.Riley Financial Kalpit Patel Initiated $20 — +34.2% $14.90
2023-01-09 Leerink Partners — Initiated $45 — +63.9% $27.46
2022-12-19 Needham — Initiated $45 — +61.4% $27.88
2022-12-16 Credit Suisse — Initiated $51 — +268.2% $13.85
2022-12-01 H.C. Wainwright — Initiated $35 — +38.5% $25.27
2022-11-15 JMP Securities — Initiated $46 — +325.1% $10.82

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. VRDN receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-12 D+ C-
2026-10-01 C- D+
2026-07-30 C C-
2026-07-27 C- C
2026-05-08 D+ C-
2026-05-05 C- D+
2026-03-02 D+ C-
2026-02-26 C D+
2026-01-16 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 28 Grade D
Profitability
20
Balance Sheet
36
Earnings Quality
45
Growth
61
Value
38
Momentum
58
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. VRDN scores highest in Growth (61/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.80
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✗ ✓ ✗ ✗ ✓
Beneish M-Score
4.28
Possible Manipulator
Ohlson O-Score
-6.17
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB-
Score: 36.7/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.86x
Accruals: -6.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. VRDN scores 0.80, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. VRDN scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. VRDN's score of 4.28 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. VRDN's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. VRDN receives an estimated rating of BB- (score: 36.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.72x
PEG
-0.75x
P/S
37.78x
P/B
3.87x
P/FCF
-5.92x
P/OCF
—
EV/EBITDA
-3.38x
EV/Revenue
17.48x
EV/EBIT
-3.38x
EV/FCF
-3.71x
Earnings Yield
-19.53%
FCF Yield
-16.91%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. VRDN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.051
EBT / EBIT
×
EBIT Margin
-5.174
EBIT / Rev
×
Asset Turnover
0.085
Rev / Assets
×
Equity Multiplier
1.427
Assets / Equity
=
ROE
-65.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. VRDN's ROE of -65.7% is driven by Asset Turnover (0.085), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$24.09
Median 1Y
$16.88
5th Pctile
$3.49
95th Pctile
$81.98
Ann. Volatility
90.5%
Analyst Target
$37.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Stephen Mahoney,
Chief Executive Officer
$700,000 $1,058,098 $6,776,249
Dr. Radhika Tripuraneni
$430,636 $— $4,080,466
Thomas Beetham, Operating
rating Officer
$545,001 $542,335 $3,761,182
Seth Harmon, Financial
ancial Officer
$480,000 $361,230 $2,642,779
Jennifer Tousignant, Legal
Legal Officer
$469,911 $297,985 $2,351,915

CEO Pay Ratio

18:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,776,249
Avg Employee Cost (SGA/emp): $378,234
Employees: 252

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
252
+76.2% YoY
Revenue / Employee
$281,147
Rev: $70,849,000
Profit / Employee
$-1,359,528
NI: $-342,601,000
SGA / Employee
$378,234
Avg labor cost proxy
R&D / Employee
$1,344,956
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -1.3% -51.6% -63.6% -81.5% -36.8% -44.6% -66.6% -86.5% -62.6% -56.8% -46.8% -54.0% -51.9% -48.5% -51.9% -65.9% -49.9% -49.2% -58.1% -65.7% -65.74%
ROA -1.1% -47.4% -56.6% -68.2% -34.2% -40.7% -60.5% -75.9% -56.3% -51.4% -42.9% -48.7% -46.7% -43.8% -47.8% -58.9% -44.8% -41.7% -49.7% -46.1% -46.08%
ROIC 12.7% 7.2% 8.4% 5.5% 5.3% 4.4% 7.9% 12.9% 21.3% 14.1% 19.6% 9.4% 9.1% 9.5% 24.3% 10.9% -7.2% 2.8% 4.1% 4.2% 4.18%
ROCE -34.5% -41.9% -51.6% -66.5% -27.5% -33.4% -49.4% -62.5% -73.0% -51.8% -36.4% -41.8% -34.8% -38.4% -48.7% -64.4% -56.9% -40.3% -47.4% -35.6% -35.61%
Gross Margin -38.0% -103.6% -81.2% -83.8% -17.5% -373.4% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% -1.4% 1.0% 1.0% 1.00%
Operating Margin -68.0% -135.9% -119.9% -115.5% -24.9% -467.3% -739.5% -823.3% -711.4% -992.8% -776.3% -1002.6% -970.7% -1214.9% -1303.7% -1423.6% -56.7% -929.9% -823.9% -444.6% -444.61%
Net Margin -67.5% -135.3% -118.9% -115.2% -24.2% -436.0% -695.4% -764.8% -661.9% -928.6% -674.2% -902.7% -891.7% -1107.3% -1207.1% -1343.1% -49.0% -911.8% -744.0% -447.6% -447.60%
EBITDA Margin -67.8% -135.7% -119.7% -115.3% -24.9% -466.4% -692.7% -760.6% -709.6% -913.8% -664.0% -892.4% -878.5% -1093.7% -1197.3% -1334.8% -48.1% -864.3% -718.6% -417.9% -417.94%
FCF Margin -17.0% -18.5% -37.4% -76.4% -40.9% -53.4% -81.9% -110.7% -522.5% -589.4% -584.0% -586.2% -653.7% -771.0% -928.3% -1015.1% -4.6% -3.9% -4.3% -4.7% -4.71%
OCF Margin -16.9% -18.4% -37.1% -75.5% -40.6% -53.0% -81.5% -110.1% -519.3% -586.5% -581.3% -584.2% -652.3% -769.3% -926.3% -1013.3% -4.6% -3.9% -4.3% -4.7% -4.69%
ROE 3Y Avg snapshot only -56.11%
ROE 5Y Avg snapshot only -60.03%
ROA 3Y Avg snapshot only -44.43%
ROIC Economic snapshot only -35.43%
Cash ROA snapshot only -30.38%
NOPAT Margin snapshot only -4.50%
Pretax Margin snapshot only -5.44%
R&D / Revenue snapshot only 4.56%
SGA / Revenue snapshot only 2.13%
SBC / Revenue snapshot only 75.38%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -1.30 -2.78 -5.58 -3.27 -6.12 -9.12 -6.24 -5.20 -3.09 -4.55 -4.90 -3.64 -5.88 -5.68 -3.56 -3.32 -5.84 -7.70 -5.54 -5.12 -6.720
P/S Ratio 65.63 74.62 279.56 359.29 367.92 668.29 649.72 700.00 1929.86 3446.08 3714.74 2884.54 5003.50 5081.45 3630.86 3739.92 24.93 37.25 28.19 27.86 37.782
P/B Ratio 0.90 1.18 2.90 2.26 1.69 3.00 3.07 3.26 2.36 2.45 1.84 1.57 2.14 2.28 1.81 2.21 3.51 3.65 3.14 2.99 3.865
P/FCF -3.86 -4.03 -7.48 -4.70 -8.99 -12.51 -7.93 -6.33 -3.69 -5.85 -6.36 -4.92 -7.65 -6.59 -3.91 -3.68 -5.41 -9.53 -6.58 -5.92 -5.915
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA 0.41 -0.31 -3.54 -1.68 -2.33 -5.71 -4.01 -3.48 -1.69 -2.61 -2.18 -1.22 -3.07 -3.15 -1.58 -1.76 -4.34 -5.43 -3.69 -3.38 -3.378
EV/Revenue -10.49 8.32 178.37 184.75 141.36 431.67 426.90 476.34 1087.82 1992.83 1658.74 973.40 2579.23 2775.20 1593.07 1962.82 18.33 25.62 18.17 17.48 17.478
EV/EBIT 0.41 -0.31 -3.54 -1.67 -2.33 -5.70 -4.00 -3.47 -1.69 -2.61 -2.17 -1.22 -3.07 -3.14 -1.58 -1.76 -4.33 -5.43 -3.69 -3.38 -3.378
EV/FCF 0.62 -0.45 -4.77 -2.42 -3.45 -8.08 -5.21 -4.30 -2.08 -3.38 -2.84 -1.66 -3.95 -3.60 -1.72 -1.93 -3.98 -6.56 -4.24 -3.71 -3.711
Earnings Yield -76.8% -35.9% -17.9% -30.6% -16.3% -11.0% -16.0% -19.2% -32.4% -22.0% -20.4% -27.5% -17.0% -17.6% -28.1% -30.2% -17.1% -13.0% -18.0% -19.5% -19.53%
FCF Yield -25.9% -24.8% -13.4% -21.3% -11.1% -8.0% -12.6% -15.8% -27.1% -17.1% -15.7% -20.3% -13.1% -15.2% -25.6% -27.1% -18.5% -10.5% -15.2% -16.9% -16.91%
Price/Tangible Book snapshot only 3.039
EV/Gross Profit snapshot only 17.557
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 15.20 14.68 12.47 7.77 17.35 12.73 12.64 12.09 13.93 18.26 23.99 15.82 18.55 15.43 19.49 11.01 11.28 12.65 15.15 16.95 16.949
Quick Ratio 15.20 14.68 12.47 7.77 17.35 12.93 12.93 12.09 13.93 18.26 23.99 15.82 18.55 15.43 19.49 11.01 11.28 12.65 15.15 16.95 16.949
Debt/Equity 0.00 0.00 0.00 0.04 0.01 0.01 0.02 0.02 0.07 0.05 0.04 0.04 0.03 0.03 0.04 0.04 0.05 0.07 0.08 0.37 0.367
Net Debt/Equity -1.04 -1.05 -1.05 -1.10 -1.04 -1.06 -1.05 -1.04 -1.03 -1.03 -1.02 -1.04 -1.03 -1.04 -1.02 -1.05 -0.93 -1.14 -1.12 -1.12 -1.116
Debt/Assets 0.00 0.00 0.00 0.03 0.01 0.01 0.01 0.02 0.06 0.04 0.03 0.04 0.03 0.03 0.03 0.04 0.04 0.06 0.06 0.22 0.221
Debt/EBITDA -0.01 -0.01 -0.01 -0.05 -0.05 -0.04 -0.03 -0.03 -0.09 -0.09 -0.10 -0.09 -0.08 -0.08 -0.07 -0.06 -0.08 -0.15 -0.15 -0.66 -0.660
Net Debt/EBITDA 3.00 2.47 2.01 1.58 3.73 3.13 2.09 1.63 1.31 1.91 2.70 2.40 2.89 2.61 2.02 1.59 1.56 2.46 2.03 2.01 2.007
Interest Coverage -396.58 -26576.00 -29034.00 -628.46 -356.13 -276.35 -270.97 -304.27 -203.07 -129.97 -96.97 -85.01 -81.82 -87.62 -100.25 -115.16 -118.92 -40.44 -31.36 -19.43 -19.435
Equity Multiplier 1.08 1.09 1.10 1.20 1.08 1.10 1.10 1.11 1.16 1.11 1.08 1.11 1.09 1.11 1.09 1.13 1.15 1.25 1.24 1.66 1.657
Cash Ratio snapshot only 15.386
Debt Service Coverage snapshot only -19.434
Cash to Debt snapshot only 4.041
FCF to Debt snapshot only -1.379
Defensive Interval snapshot only 810.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.09 0.10 0.08 0.085
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover (trade) 10.46 13.14 1.82 0.65 4.29 6.41 5.09 3.70 1.39 3.08 2.50 5.65 5.21 5.92 5.92 — 2.02 — — 1.90 1.897
Payables Turnover 25.11 37.94 20.54 21.69 10.57 12.18 15.97 15.00 4.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.04 0.04 0.037
DSO (trade) 35 28 201 560 85 57 72 99 263 119 146 65 70 62 62 0 181 0 0 192 192.4 days
DIO 0 0 0 0 0 -12 -19 0 0 — — — — — — — — 0 0 0 0.0 days
DPO 15 10 18 17 35 30 23 24 74 — — — — — — — — 6174 9809 9792 9792.3 days
Cash Conversion Cycle (trade) 20 18 183 543 51 15 30 74 189 — — — — — — — — -6174 -9809 -9600 -9599.8 days
Fixed Asset Turnover snapshot only 14.665
Cash Velocity snapshot only 0.072
Capital Intensity snapshot only 15.426
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 49.4% 1.8% 3.3% -65.5% -32.9% -40.2% -4.3% 64.4% -81.6% -82.3% -82.6% -80.4% -13.0% -3.8% 4.9% 5.9% 233.4% 233.6% 233.8% 232.2% 232.20%
Net Income -3.7% 28.3% 28.5% 26.0% 20.0% -63.5% -98.9% -1.0% -91.7% -83.0% -26.6% -15.2% -18.7% -13.6% -41.3% -50.9% -17.5% -26.9% -17.0% -12.5% -12.47%
EPS -56.1% 74.8% 82.7% 78.4% 73.5% 54.9% -23.0% -29.4% -48.2% -49.4% 12.5% 21.9% 22.0% 29.5% -6.2% -18.1% 4.6% -19.8% 6.9% 14.9% 14.94%
FCF -69.1% -84.4% -96.5% -67.5% -61.4% -72.3% -1.1% -1.4% -1.4% -95.6% -24.1% -3.8% -8.9% -25.8% -66.7% -83.4% -65.3% -18.9% -8.4% -8.2% -8.22%
EBITDA -1.6% -98.3% -71.2% -57.6% -60.2% -68.4% -1.0% -1.0% -95.1% -78.7% -24.6% -13.7% -13.8% -11.2% -38.9% -48.8% -18.0% -25.5% -14.7% -8.0% -8.05%
Op. Income -3.7% 27.8% 28.0% 25.5% 19.1% -68.5% -1.1% -1.1% -1.0% -89.5% -31.5% -19.1% -22.0% -17.5% -41.7% -48.2% -15.9% -21.5% -14.4% -9.0% -9.05%
OCF Growth snapshot only -7.86%
Asset Growth snapshot only 88.42%
Equity Growth snapshot only 28.52%
Debt Growth snapshot only 10.38%
Shares Change snapshot only 32.22%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -32.5% -29.3% -24.2% -40.8% -22.6% -26.5% -30.5% -17.0% -43.0% -33.1% -44.4% -51.9% -52.4% -53.3% -44.1% -30.1% 2.4% 2.4% 2.5% 2.6% 2.64%
Revenue 5Y -2.9% -2.3% -10.3% -20.6% -12.0% -15.0% -27.6% -31.6% -48.0% -48.2% -40.8% -41.8% -40.5% -41.6% -42.8% -34.7% 1.1% 1.3% 1.1% 93.9% 93.90%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 42.4% 45.5% 49.4% 51.6% 1.2% 1.4% 1.1% 1.2% 1.2% 55.2% 72.5% 70.5% 51.7% 53.9% 53.4% 50.8% 9.4% 27.4% 26.8% 46.2% 46.15%
Assets 5Y 96.6% 1.2% 25.9% 27.7% 56.4% 52.7% 34.8% 33.8% 33.8% 49.3% 62.9% 64.4% 81.9% 89.6% 76.1% 77.0% 77.4% 46.9% 45.1% 56.1% 56.15%
Equity 3Y 49.9% 54.1% 59.6% 61.9% 1.6% 1.9% 1.4% 1.5% 1.4% 54.4% 76.5% 74.9% 51.2% 52.9% 53.6% 53.7% 7.1% 22.3% 22.0% 28.0% 27.98%
Book Value 3Y -14.9% -12.4% -31.6% -31.9% 2.7% 10.1% -2.3% 6.9% 4.7% -33.7% -17.1% -12.1% -16.5% -20.6% 5.2% 7.3% -20.2% -4.4% -9.2% -5.6% -5.63%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.11 0.12 0.19 0.38 0.50 0.41 0.87 0.79 0.79 0.71 0.87 0.90 0.96 0.96 0.90 0.81 0.39 0.40 0.39 0.38 0.380
Earnings Stability 0.59 0.74 0.70 0.67 0.65 0.80 0.79 0.79 0.80 0.80 0.86 0.87 0.88 0.87 0.90 0.90 0.93 0.90 0.91 0.91 0.907
Margin Stability 0.00 0.06 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.89 0.89 0.90 0.92 0.50 0.50 0.50 0.50 0.50 0.89 0.94 0.93 0.95 0.83 0.50 0.93 0.89 0.93 0.95 0.950
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.93 1.37 0.76 0.82 0.78 0.34 0.34 0.39 -0.28 -0.16 0.13 0.23 0.16 0.03 -0.08 -0.14 -0.04 -0.00 -0.12 -0.04 -0.035
Gross Margin Trend -11.77 -8.26 -24.07 -67.25 -34.06 -40.07 -23.99 5.36 -82.11 38.07 42.74 60.03 78.97 28.47 25.14 20.90 56.65 -0.00 -0.00 -0.00 -0.004
FCF Margin Trend -4.99 -0.30 -24.22 -62.23 -24.90 -29.96 -53.41 -64.62 -493.49 -553.42 -524.39 -492.66 -372.06 -449.56 -595.32 -666.66 583.49 676.27 751.88 795.92 795.919
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.34 0.69 0.74 0.69 0.68 0.72 0.78 0.82 0.83 0.77 0.77 0.74 0.77 0.86 0.91 0.90 1.08 0.81 0.84 0.86 0.861
FCF/OCF 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.005
FCF/Net Income snapshot only 0.866
CapEx/Revenue 7.2% 11.4% 29.1% 82.8% 34.6% 45.0% 44.3% 52.5% 3.1% 2.9% 2.7% 1.9% 1.5% 1.7% 2.0% 1.8% 0.5% 0.7% 0.6% 2.4% 2.38%
CapEx/Depreciation snapshot only 212.000
Accruals Ratio -0.74 -0.15 -0.15 -0.21 -0.11 -0.11 -0.13 -0.14 -0.09 -0.12 -0.10 -0.13 -0.11 -0.06 -0.04 -0.06 0.04 -0.08 -0.08 -0.06 -0.064
Sloan Accruals snapshot only 0.585
Cash Flow Adequacy snapshot only -196.547
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -61.9% -51.7% -23.5% -33.1% -38.8% -24.7% -27.2% -28.4% -3.7% -11.6% -29.1% -37.5% -36.1% -29.6% -24.8% -23.9% -2.8% -13.0% -17.2% -24.7% -24.69%
Total Shareholder Return -61.9% -51.7% -23.5% -33.1% -38.8% -24.7% -27.2% -28.4% -3.7% -11.6% -29.1% -37.5% -36.1% -29.6% -24.8% -23.9% -2.8% -13.0% -17.2% -24.7% -24.69%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.98 1.00 0.99 0.99 0.99 0.97 0.98 0.98 0.97 0.99 0.99 0.99 1.01 1.01 1.01 1.01 1.01 1.02 1.03 1.05 1.051
EBIT Margin -25.47 -26.91 -50.41 -110.37 -60.78 -75.79 -106.65 -137.23 -643.15 -764.49 -763.96 -796.94 -840.99 -883.78 -1010.84 -1118.36 -4.23 -4.72 -4.93 -5.17 -5.174
Asset Turnover 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.09 0.10 0.08 0.085
Equity Multiplier 1.13 1.09 1.12 1.20 1.08 1.10 1.10 1.14 1.11 1.11 1.09 1.11 1.11 1.11 1.09 1.12 1.11 1.18 1.17 1.43 1.427
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-12.63 $-7.10 $-3.32 $-3.54 $-3.35 $-3.20 $-4.08 $-4.58 $-4.96 $-4.79 $-3.57 $-3.57 $-3.87 $-3.37 $-3.79 $-4.22 $-3.69 $-4.04 $-3.53 $-3.59 $-3.59
Book Value/Share $18.29 $16.78 $6.38 $5.11 $12.12 $9.74 $8.30 $7.30 $6.50 $8.90 $9.53 $8.29 $10.65 $8.39 $7.43 $6.31 $6.15 $8.52 $6.22 $6.14 $6.14
Tangible Book/Share $18.29 $16.78 $6.38 $5.11 $12.12 $9.74 $8.30 $7.30 $6.50 $8.90 $9.53 $8.29 $10.65 $8.39 $7.43 $6.31 $6.15 $8.52 $6.22 $6.04 $6.04
Revenue/Share $0.25 $0.26 $0.07 $0.03 $0.06 $0.04 $0.04 $0.03 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.87 $0.84 $0.69 $0.66 $0.66
FCF/Share $-4.26 $-4.91 $-2.47 $-2.46 $-2.28 $-2.33 $-3.21 $-3.76 $-4.15 $-3.73 $-2.75 $-2.64 $-2.97 $-2.91 $-3.45 $-3.79 $-3.99 $-3.27 $-2.97 $-3.11 $-3.11
OCF/Share $-4.25 $-4.88 $-2.45 $-2.43 $-2.26 $-2.31 $-3.19 $-3.74 $-4.13 $-3.71 $-2.74 $-2.64 $-2.97 $-2.90 $-3.44 $-3.79 $-3.99 $-3.26 $-2.97 $-3.09 $-3.09
Cash/Share $19.12 $17.61 $6.71 $5.81 $12.78 $10.47 $8.85 $7.73 $7.17 $9.61 $10.04 $8.95 $11.34 $8.96 $7.83 $6.90 $6.00 $10.31 $7.46 $9.10 $9.10
EBITDA/Share $-6.37 $-7.12 $-3.33 $-3.55 $-3.38 $-3.31 $-4.17 $-4.65 $-5.10 $-4.82 $-3.59 $-3.59 $-3.82 $-3.33 $-3.75 $-4.17 $-3.66 $-3.94 $-3.42 $-3.41 $-3.41
Debt/Share $0.04 $0.05 $0.02 $0.19 $0.15 $0.13 $0.13 $0.13 $0.48 $0.42 $0.34 $0.33 $0.32 $0.26 $0.26 $0.26 $0.29 $0.60 $0.50 $2.25 $2.25
Net Debt/Share $-19.08 $-17.57 $-6.69 $-5.62 $-12.63 $-10.34 $-8.72 $-7.60 $-6.69 $-9.18 $-9.69 $-8.62 $-11.02 $-8.70 $-7.57 $-6.64 $-5.71 $-9.72 $-6.96 $-6.85 $-6.85
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.800
Altman Z-Prime snapshot only 3.945
Piotroski F-Score 3 6 3 3 4 1 3 5 2 3 3 3 4 3 3 2 1 2 2 4 4
Beneish M-Score — 0.78 -4.03 -4.62 1.24 -3.79 -47.07 -50.18 -17.10 -201.56 -3.27 -3.99 -3.51 -3.62 -3.68 -2.85 734.09 -2.34 -1.73 4.28 4.284
Ohlson O-Score snapshot only -6.169
ROIC (Greenblatt) snapshot only -36.00%
Net-Net WC snapshot only $5.99
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB-
Credit Score 59.35 60.99 61.93 53.11 64.09 65.50 64.75 65.05 65.45 65.69 65.06 65.43 65.07 65.32 65.56 65.09 65.39 64.91 64.88 36.73 36.727
Credit Grade snapshot only 13
Credit Trend snapshot only -28.368
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 31
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms